» Articles » PMID: 21837265

Hepatic Endosome Protein Profiling in Apolipoprotein E Deficient Mice Expressing Apolipoprotein B48 but Not B100

Overview
Date 2011 Aug 13
PMID 21837265
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Liver cells absorb apolipoprotein (Apo) B48-carrying lipoproteins in ApoE's absence, albeit not as efficiently as the ApoE-mediated process. Our objective was to identify differentially expressed hepatic endosome proteins in mice expressing ApoB48 but lacking ApoE and ApoB100 expression (ApoE-/-/B48/48). We purified early and late endosomes from ApoE-/-/B48/48 and wild-type mouse's livers. In ApoE-/-/B48/48 mouse's hepatic endosomes, proteomic analysis revealed elevated protein levels of major urinary protein 6 (MUP), calreticulin, protein disulfide isomerases (PDI) A1, and A3. These proteins are capable of interacting with lipids/lipoproteins and triggering receptor-mediated endocytosis. In addition, hepatic endosomes from ApoE-/- /B48/48 mice exhibited significantly reduced protein levels of haptoglobin, hemopexin, late endosome/lysosome interacting protein, cell division control protein 2 homolog, γ-soluble Nethylmaleimide- sensitive factor attachment protein, vacuolar ATP synthase catalytic subunit A1, dipeptidyl peptidases II, cathepsin B, D, H, and Z. These proteins participate in plasma heme clearance, receptor-mediated signaling, membrane fusion, endosomal/lysosomal acidification, and protein degradation. The significance of increasing endosomal MUP, calreticulin and PDIs in ApoE-/-/B48/48 mouse liver cells is not clear; however, reducing endosomal/ lysosomal membrane proteins and hydrolases might be, at least partially, responsible for the retarded clearance of plasma ApoB-carrying lipoproteins in ApoE-/-/B48/48 mice.

Citing Articles

Potential role of ATM in hepatocyte endocytosis of ApoE-deficient, ApoB48-containing lipoprotein in ApoE-deficient mice.

Wu J, Xiao Y, Liu J, Yang H, Dong X, Hu S Int J Mol Med. 2013; 33(2):462-8.

PMID: 24276232 PMC: 4035781. DOI: 10.3892/ijmm.2013.1566.

References
1.
Piedrahita J, Zhang S, Hagaman J, Oliver P, Maeda N . Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A. 1992; 89(10):4471-5. PMC: 49104. DOI: 10.1073/pnas.89.10.4471. View

2.
Berwin B, Delneste Y, Lovingood R, Post S, Pizzo S . SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin. J Biol Chem. 2004; 279(49):51250-7. DOI: 10.1074/jbc.M406202200. View

3.
Schwartz C, VandenBroek J, Cooper P . Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J Lipid Res. 2004; 45(9):1594-607. DOI: 10.1194/jlr.M300511-JLR200. View

4.
Faust P, Wall D, Perara E, Lingappa V, Kornfeld S . Expression of human cathepsin D in Xenopus oocytes: phosphorylation and intracellular targeting. J Cell Biol. 1987; 105(5):1937-45. PMC: 2114857. DOI: 10.1083/jcb.105.5.1937. View

5.
Ghebrehiwet B, Peerschke E . cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol. 2004; 41(2-3):173-83. DOI: 10.1016/j.molimm.2004.03.014. View